폴립 생검 시장 보고서(2025년)
Polyp Biopsy Global Market Report 2025
상품코드 : 1855958
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

폴립 생검 시장 규모는 최근 몇 년 동안 강력하게 성장하고 있습니다. 2024년 12억 7,000만 달러로 평가되었고, 2025년에는 13억 9,000만 달러에 달하고, CAGR 8.7%로 성장할 전망입니다. 역사적인 기간의 성장은 대장암 검진에 대한 의식 증가, 소화기 질환 유병률의 상승, 병원과 진단 인프라의 확대, 정부 지원의 검진 프로그램, 생검 겸자의 기술 진보에 기인하고 있습니다.

폴립 생검 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.3%로 19억 1,000만 달러로 성장할 전망입니다. 예측 기간에 있어서의 성장의 원동력은 저침습 수기에 대한 수요 증가, 일회용 생검 기기의 채택 확대, 조기 암 발견에 대한 헬스케어 투자, 진단 수술에 대한 보험 적용의 확대, 세계 인구의 고령화에 의한 검진율의 향상입니다. 예측기간의 주요 동향으로는 생검 분석에 있어서의 인공지능의 통합, 로봇 지원 생검 수술의 개발, 일회용 및 일회용 기기 사용 증가, 외래·외래 진료 센터 선호, 맞춤형 의료·정밀 진단에의 전환 등을 들 수 있습니다.

대장암의 유병률 증가는 폴립 생검 시장 확대에 크게 기여할 것으로 예측됩니다. 대장암은 대장을 뒷받침하는 상피 세포의 비정상적이고 통제 불가능한 증식으로 인한 결장 또는 직장에서 발생하는 악성 질환입니다. 이 유형의 암은 인근 조직에 침투하여 신체의 다른 부분으로 전이하는 능력으로 알려져 있습니다. 대장암 환자 증가는 가공식품이 많고 식이섬유가 적은 일반적인 식습관에 크게 기인하고 있습니다. 이러한 식습관은 만성 염증을 일으키고, 장내 세균 군집을 방해하고, 곧 암화할 가능성이 있는 전암성 증식의 형성을 촉진합니다. 폴립 생검은 비정상 병변의 조기 발견과 조직학적 검사를 용이하게 함으로써 적시에 치료를 가능하게 하고 질환의 진행 위험을 저감함으로써 이 동향을 대처하는데 중요한 역할을 하고 있습니다. 예를 들어 미국을 거점으로 하는 비영리단체인 미국암협회는 2025년에는 국내에서 새롭게 결장암이 107,320건, 직장암이 46,950건 발생하고, 약 52,900명이 사망할 것으로 추정하고 있습니다. 이와 같이, 결장직장암의 이환율 증가는 폴립 생검 처치 수요를 부추기고 있습니다.

폴립 생검 시장의 주요 기업은 대장 폴립의 동정을 개선하고 암의 가능성이 있는 병변의 조기 발견을 가능하게 하기 위해 인공지능 지원 검출 시스템 등의 첨단 기술에 투자하고 있습니다. 인공지능 지원 검출 시스템은 이미지 데이터를 실시간으로 평가하여 이상을 검출하고 의료 종사자에게 시각적인 경고를 생성하는 의료 도구로, 치료법을 제공하지 않고 충분한 정보에 기초한 임상 판단을 지원합니다. 예를 들어 2024년 9월 미국에 본사를 둔 올림푸스 주식회사와 제휴한 의료기술 기업인 Odin Medical Ltd.는 클라우드 기반 인공지능 내시경 플랫폼인 CADDIE를 발표했습니다. CADDIE 시스템은 대장 내시경 검사 영상을 실시간으로 분석하여 대장 폴립이 있을 수 있는 부위를 확인하고 임상가가 검사 중에 보다 적절한 판단을 내릴 수 있도록 합니다. 임상 평가는 이 시스템이 검사에 소요되는 시간과 위험을 증가시키지 않고 선종의 검출률을 향상시키는 것으로 나타났으며, 조기 진단 지원과 환자 관리 개선에 효과적임을 입증했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

A polyp biopsy is a medical procedure in which a healthcare professional removes a small tissue sample from an abnormal growth, or polyp, on the lining of an organ or body cavity. The sample is examined under a microscope to assess cellular characteristics, detect disease, and support accurate diagnosis and treatment planning. This procedure helps determine the nature of polyps, distinguish between benign and malignant conditions, and provide critical information for guiding clinical management or surveillance strategies.

The primary types of polyp biopsy are colonoscopy, colposcopy-directed biopsy, esophagogastroduodenoscopy, and laryngoscopy. Colonoscopy with polyp biopsy involves inserting a flexible camera (colonoscope) into the colon to visualize the intestinal lining and remove tissue samples for diagnostic evaluation. Techniques include endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and conventional biopsy. These procedures are distributed through online channels, retail pharmacies, and other outlets, and are applied in areas such as colorectal cancer and gastrointestinal disorders. End-users include hospitals, diagnostic laboratories, and specialty clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The polyp biopsy market research report is one of a series of new reports from The Business Research Company that provides polyp biopsy market statistics, including polyp biopsy industry global market size, regional shares, competitors with a polyp biopsy market share, detailed polyp biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the polyp biopsy industry. This polyp biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The polyp biopsy market size has grown strongly in recent years. It will grow from $1.27 billion in 2024 to $1.39 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period is attributed to increasing awareness of colorectal cancer screening, rising prevalence of gastrointestinal disorders, expansion of hospital and diagnostic infrastructure, government-supported screening programs, and technological advancements in biopsy forceps.

The polyp biopsy market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period is driven by rising demand for minimally invasive procedures, increased adoption of disposable biopsy devices, healthcare investments in early cancer detection, expanding insurance coverage for diagnostic procedures, and an aging global population boosting screening rates. Key trends in the forecast period include the integration of artificial intelligence in biopsy analysis, development of robotic-assisted biopsy procedures, growing use of disposable and single-use devices, preference for outpatient and ambulatory care centers, and a shift toward personalized medicine and precision diagnostics.

The growing prevalence of colorectal cancer is expected to contribute significantly to the expansion of the polyp biopsy market. Colorectal cancer is a malignant condition that develops in the colon or rectum, originating from abnormal and uncontrolled growth of epithelial cells lining the large intestine. This form of cancer is known for its ability to invade nearby tissues and spread to other parts of the body. The increase in colorectal cancer cases is largely attributed to common dietary habits that are high in processed foods and low in fiber. These habits can cause chronic inflammation, disrupt gut microbiota, and encourage the formation of precancerous growths that may eventually become cancerous. Polyp biopsy plays a critical role in addressing this trend by facilitating early detection and histological examination of abnormal lesions, thereby enabling timely treatment and reducing the risk of disease progression. For example, in 2025, the American Cancer Society, a nonprofit organization based in the United States, estimated that there would be 107,320 new cases of colon cancer and 46,950 new cases of rectal cancer in the country, with approximately 52,900 deaths expected as a result. As such, the rising incidence of colorectal cancer is fueling demand for polyp biopsy procedures.

Key companies in the polyp biopsy market are investing in advanced technologies such as artificial intelligence-assisted detection systems to improve the identification of colorectal polyps and enable earlier recognition of potentially cancerous lesions. An artificial intelligence-assisted detection system is a medical tool that evaluates imaging data in real time to detect abnormalities and generate visual alerts for healthcare providers, assisting them in making informed clinical decisions without delivering therapeutic treatments. For example, in September 2024, Odin Medical Ltd., a medical technology firm based in the United States and affiliated with Olympus Corporation, introduced CADDIE, a cloud-based artificial intelligence endoscopy platform. The CADDIE system analyzes colonoscopy footage in real time, identifying areas that may contain colorectal polyps and allowing clinicians to make better decisions during the examination. Clinical evaluations showed that the system improves the rate of adenoma detection without increasing the time or risk involved in the procedure, demonstrating its effectiveness in supporting early diagnosis and improving patient care.

In October 2024, Caldera Medical, a medical device manufacturer based in the United States, acquired UVision360, Inc. for an undisclosed amount. Through this acquisition, Caldera Medical gains access to UVision360's advanced hysteroscopy technology, including the LUMINELLE Bx system, which enhances the company's offerings in minimally invasive diagnostic and treatment options for uterine conditions such as polyps, fibroids, and other intrauterine abnormalities. UVision360 is a company based in the United States that develops hysteroscopy and cystoscopy systems, including the LUMINELLE platform.

Major players in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., Cooper Surgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical.

North America was the largest region in the polyp biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polyp biopsy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the polyp biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The polyp biopsy market consists of revenues earned by entities by providing services such as endoscopic ultrasound (EUS), capsule endoscopy, double-balloon enteroscopy, single-balloon enteroscopy, push enteroscopy, transnasal endoscopy, and transanal endoscopic microsurgery (TEM). The market value includes the value of related goods sold by the service provider or included within the service offering. The polyp biopsy market also includes sales of hot biopsy forceps, cold biopsy forceps, endoscopic snares, polypectomy snares, cytology brushes, biopsy needles (fine-needle aspiration needles, core biopsy needles), and endoscopic ultrasound needles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polyp Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on polyp biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for polyp biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The polyp biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Polyp Biopsy Market Characteristics

3. Polyp Biopsy Market Trends And Strategies

4. Polyp Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Polyp Biopsy Growth Analysis And Strategic Analysis Framework

6. Polyp Biopsy Market Segmentation

7. Polyp Biopsy Market Regional And Country Analysis

8. Asia-Pacific Polyp Biopsy Market

9. China Polyp Biopsy Market

10. India Polyp Biopsy Market

11. Japan Polyp Biopsy Market

12. Australia Polyp Biopsy Market

13. Indonesia Polyp Biopsy Market

14. South Korea Polyp Biopsy Market

15. Western Europe Polyp Biopsy Market

16. UK Polyp Biopsy Market

17. Germany Polyp Biopsy Market

18. France Polyp Biopsy Market

19. Italy Polyp Biopsy Market

20. Spain Polyp Biopsy Market

21. Eastern Europe Polyp Biopsy Market

22. Russia Polyp Biopsy Market

23. North America Polyp Biopsy Market

24. USA Polyp Biopsy Market

25. Canada Polyp Biopsy Market

26. South America Polyp Biopsy Market

27. Brazil Polyp Biopsy Market

28. Middle East Polyp Biopsy Market

29. Africa Polyp Biopsy Market

30. Polyp Biopsy Market Competitive Landscape And Company Profiles

31. Polyp Biopsy Market Other Major And Innovative Companies

32. Global Polyp Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Polyp Biopsy Market

34. Recent Developments In The Polyp Biopsy Market

35. Polyp Biopsy Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기